Hormone replacement therapy and risk of acute myocardial infarction in postmenopausal women with diabetes mellitus

American Journal of Cardiology

Volumn 91, Issue 10, 2003, Pages 1275-1277

  Gami, Apoor S ^a   Wright, R Scott ^a   Ballman, Karla V ^a   Kopecky, Stephen L ^a   Hayes, Sharonne N ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ESTROGEN; HORMONE; INSULIN; PROGESTERONE; STATIN;

ACUTE HEART INFARCTION; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DISEASE ASSOCIATION; DRUG USE; FEMALE; HORMONE SUBSTITUTION; HUMAN; INFORMATION PROCESSING; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; OVARIECTOMY; PATIENT SELECTION; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0038740486     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(03)00284-4     Document Type: Article

References (11)

1. Stampfer M.J. Estrogen replacement and coronary heart disease a quantitative assessment of the epidemiologic evidence . Prev Med. 20:1991;47-63.
2. Grodstein F., Stampfer M.J., Colditz G.A., Willett W.C., Manson J.E., Joffe M., Rosner B., Fuchs C., Hankinson S.E., Hunter D.J., Hennekens C.H., Speizer F.E. Postmenopausal hormone therapy and mortality. N Engl J Med. 336:1997;1769-1776.
3. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A., Howard B.V., Johnson K.C., Kotchen J.M., Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women principal results from the Women's Health Initiative randomized controlled trial . JAMA. 288:2002;321-333.
4. Grady D., Herrington D., Bittner V., Blumenthal R., Davidson M., Hlatky M., Hsia J., Hulley S., Herd A., Khan S., et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/progestin Replacement Study follow-up (HERS II). N Engl J Med. 288:2002;49-57.
5. Furberg C.D., Vittinghoff E., Davidson M., Herrington D.M., Simon J.A., Wenger N.K., Hulley S. Subgroup interactions in the Heart and Estrogen/progestin Replacement Study lessons learned . Circulation. 105:2002;917-922.
6. Kannel W.B. Lipids, diabetes and coronary heart disease insights from the Framingham study . Am Heart J. 110:1985;1100-1107.
7. Kleinman J., Donahue R., Harris M., Finucane F., Madans J., Brock D. Mortality among diabetics in a national sample. Am J Epidemiol. 128:1988;389-401.
8. Harris M.I. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 years. Diabetes. 36:1987;523-534.
9. Keating N.L., Cleary P.D., Rossi A.S., Zaslavsky A.M., Ayanian J.Z. Use of hormone replacement therapy by postmenopausal women in the United States. Ann Intern Med. 130:1999;545-553.
10. Gillum R.F., Fortmann S.P., Prineas R.J., Kottke T.E. WHO criteria for diagnosis of acute myocardial infarction. Am Heart J. 108:1984;150-158.
11. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 280:1998;605-613.